97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details


臨床試験数 : 2,630 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2015-003364-36-HU
(EUCTR)
09/02/201602/12/2015A study using a new drug (GED-0301) to investigate if the new drug works and is safe in subjects suffering ulcerative colitis.A Phase 2, Open-label, Multicenter Study to Explore the Efficacy and Safety of Mongersen (GED-0301) in Subjects with Active Ulcerative Colitis. Ulcerative Colitis.
MedDRA version: 18.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: Mongersen
Product Code: GED-0301
INN or Proposed INN: Mongersen
Other descriptive name: GED-0301
Celgene CorporationNULLNot RecruitingFemale: yes
Male: yes
40Phase 2United States;Hungary;Slovakia;Canada;Poland;Bulgaria
2EUCTR2015-003364-36-BG
(EUCTR)
09/02/201628/01/2016A study using a new drug (GED-0301) to investigate if the new drug works and is safe in subjects suffering ulcerative colitis.A Phase 2, Open-label, Multicenter Study to Explore the Efficacy and Safety of Mongersen (GED-0301) in Subjects with Active Ulcerative Colitis. Ulcerative Colitis.
MedDRA version: 18.1;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: Mongersen
Product Code: GED-0301
INN or Proposed INN: Mongersen
Other descriptive name: GED-0301
Celgene CorporationNULLNot RecruitingFemale: yes
Male: yes
40Phase 2United States;Hungary;Slovakia;Canada;Poland;Bulgaria
3EUCTR2015-003364-36-SK
(EUCTR)
22/01/201607/12/2015A study using a new drug (GED-0301) to investigate if the new drug works and is safe in subjects suffering ulcerative colitis.A Phase 2, Open-label, Multicenter Study to Explore the Efficacy and Safety of Mongersen (GED-0301) in Subjects with Active Ulcerative Colitis. Ulcerative Colitis.
MedDRA version: 19.0;Level: LLT;Classification code 10045365;Term: Ulcerative colitis;System Organ Class: 100000004856;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Product Name: Mongersen
Product Code: GED-0301
INN or Proposed INN: Mongersen
Other descriptive name: GED-0301
Celgene CorporationNULLNot RecruitingFemale: yes
Male: yes
40Phase 2United States;Hungary;Slovakia;Canada;Poland;Bulgaria
4NCT02601300
(ClinicalTrials.gov)
December 14, 20156/11/2015An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative ColitisA Phase 2, Open-Label, Multicenter Study to Explore the Efficacy and Safety of MONGERSON (GED-0301) in Subjects With Active Ulcerative Colitis.Colitis, UlcerativeDrug: GED-0301CelgeneNULLCompleted18 YearsN/AAll41Phase 2United States;Bulgaria;Canada;Hungary;Poland;Slovakia